Reiterating his commitment to ensure best healthcare services to the
patients, Drug Controller General of India (DCGI) Dr GN Singh has
stressed that Indian drug regulators have always maintained a strict
vigil in ensuring quality of the drugs that are manufactured throughout
the country. Dr Singh strongly defended that there have been no lapse
or compromise on quality parameters from the Indian drug regulators as
efficacy of the drugs and safety of the patients have always remained to
be the top priority.
Rubbishing claims levelled by media expressing growing concern among overseas regulators over the quality of Indian made drugs, Dr Singh pointed out that Indian drug regulatory norms are amongst one of the stringent regulatory norms followed across the globe. Which again is painstakingly implemented through professional expertise leaving no place for error because it is the life of the patients at risk.
Rubbishing claims levelled by media expressing growing concern among overseas regulators over the quality of Indian made drugs, Dr Singh pointed out that Indian drug regulatory norms are amongst one of the stringent regulatory norms followed across the globe. Which again is painstakingly implemented through professional expertise leaving no place for error because it is the life of the patients at risk.
No comments:
Post a Comment